These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 30440016

  • 21. Immunological correlates of vaccination and infection for equine herpesvirus 1.
    Goodman LB, Wimer C, Dubovi EJ, Gold C, Wagner B.
    Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
    [Abstract] [Full Text] [Related]

  • 22. Absence of relationship between type-I interferon suppression and neuropathogenicity of EHV-1.
    Oladunni FS, Sarkar S, Reedy S, Balasuriya UBR, Horohov DW, Chambers TM.
    Vet Immunol Immunopathol; 2018 Mar; 197():24-30. PubMed ID: 29475503
    [Abstract] [Full Text] [Related]

  • 23. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
    Allen GP, Breathnach CC.
    Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
    [Abstract] [Full Text] [Related]

  • 24. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 25. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA, Stanfield BA, Chouljenko VN, Naidu S, Langohr I, Del Piero F, Ferracone J, Roy AA, Kousoulas KG.
    J Virol; 2017 Jun 15; 91(12):. PubMed ID: 28404844
    [Abstract] [Full Text] [Related]

  • 26. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
    Bannai H, Tsujimura K, Kondo T, Nemoto M, Yamanaka T, Sugiura T, Maeda K, Matsumura T.
    J Vet Med Sci; 2011 Apr 15; 73(4):535-9. PubMed ID: 21139350
    [Abstract] [Full Text] [Related]

  • 27. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
    Stokes A, Corteyn AH, Murray PK.
    Res Vet Sci; 1991 Sep 15; 51(2):141-8. PubMed ID: 1664967
    [Abstract] [Full Text] [Related]

  • 28. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T, Kondo T, Sugita S, Damiani AM, O'Callaghan DJ, Imagawa H.
    Virology; 1998 Mar 01; 242(1):68-79. PubMed ID: 9501037
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR, Didlick S, Bateman H.
    Equine Vet J; 2004 Jul 01; 36(5):447-51. PubMed ID: 15253088
    [Abstract] [Full Text] [Related]

  • 30. Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.
    Sarkar S, Balasuriya UB, Horohov DW, Chambers TM.
    Vet Immunol Immunopathol; 2015 Oct 15; 167(3-4):122-9. PubMed ID: 26275803
    [Abstract] [Full Text] [Related]

  • 31. Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.
    Pusterla N, Dorman DC, Burgess BA, Goehring L, Gross M, Osterrieder K, Soboll Hussey G, Lunn DP.
    J Vet Intern Med; 2024 Oct 15; 38(3):1765-1791. PubMed ID: 38069548
    [Abstract] [Full Text] [Related]

  • 32. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 33. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
    Kydd JH, Hannant D, Robinson RS, Bryant N, Osterrieder N.
    Vaccine; 2020 Jan 10; 38(2):388-398. PubMed ID: 31629571
    [Abstract] [Full Text] [Related]

  • 34. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N, Bridges CG, Griffiths L.
    J Interferon Res; 1989 Aug 10; 9(4):389-92. PubMed ID: 2474039
    [Abstract] [Full Text] [Related]

  • 35. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G, Breathnach CC, Kydd JH, Hussey SB, Mealey RM, Lunn DP.
    Vet Immunol Immunopathol; 2010 May 15; 135(1-2):108-117. PubMed ID: 20018383
    [Abstract] [Full Text] [Related]

  • 36. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
    Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kokado H, Kondo T, Matsumura T.
    Vet Microbiol; 2018 Aug 15; 222():18-24. PubMed ID: 30080668
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP, Bolin DC, Bryant U, Carter CN, Giles RC, Harrison LR, Hong CB, Jackson CB, Poonacha K, Wharton R, Williams NM.
    Equine Vet J; 2008 Mar 15; 40(2):105-10. PubMed ID: 18089469
    [Abstract] [Full Text] [Related]

  • 38. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS, van Maanen C, Berendsen M, Cullinane A, de Groot RJ, Rottier PJ, Wesselingh JJ, Sloet van Oldruitenborgh-Oosterbaan MM.
    Vet J; 2010 Nov 15; 186(2):180-7. PubMed ID: 19726209
    [Abstract] [Full Text] [Related]

  • 39. Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals.
    Gardiner DW, Lunn DP, Goehring LS, Chiang YW, Cook C, Osterrieder N, McCue P, Del Piero F, Hussey SB, Hussey GS.
    Vaccine; 2012 Oct 12; 30(46):6564-72. PubMed ID: 22944628
    [Abstract] [Full Text] [Related]

  • 40. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
    Paillot R, Daly JM, Juillard V, Minke JM, Hannant D, Kydd JH.
    Vaccine; 2005 Aug 22; 23(36):4541-51. PubMed ID: 15913852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.